Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
17
self-reported 2–10 band
Founded
2022
4 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
1
Pre seed · Oct 2023 · US$ 120.0K
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
MISTI PTY LTD
ABN55659820818
Legal entities
Show as table · Misti: 1 registry entity
| MISTI PTY LTD | ABN 55659820818 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Misti is an Australian MedTech company pioneering MedMisti™—a patented, hospital-grade smart inhaler designed for targeted lung delivery of advanced therapeutics.
Respiratory diseases such as asthma, COPD, influenza, COVID-19, and RSV continue to pose global health challenges, with poor adherence and device misuse undermining treatment outcomes. Traditional inhalers often clog, degrade sensitive molecules, and offer only short-term relief.
MedMisti™ overcomes these barriers with a breath-triggered, cloud-connected, clog-resistant design that increases deep lung delivery by 1.8x while preserving therapeutic integrity. The platform is engineered to deliver a wide range of biomolecules—including mRNA, antibodies, small molecules, and antigens—positioning it as a first-in-class solution for both chronic and infectious respiratory conditions.
Built for clinical-grade reliability and digital integration, MedMisti™ is redefining respiratory care through precision delivery, patient engagement, and global scalability.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUMelbourne, VictoriaPrimary
Grid intelligence Members
Funding
Rounds1
Round typePre seed · venture round
Amount (USD)120,000
Stage rank1
Investors named1
Since last round2 yr 3 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2022 to 2026 |
| Pre seed · 15 Oct 2023 | US$ 120.0K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Misti?
One Victoria entity on the ABR. MISTI PTY LTD (ABN 55 659 820 818), high confidence.
How many people work at Misti?
The record holds 17 counted staff profiles at January 2026, above the self-reported 2–10 band.
Where does Misti have offices?
One address on record, Australia only. Primary: Melbourne, Victoria.
Has Misti raised funding?
One round. Latest 15 October 2023: pre seed, US$120,000, investor Startmate.
Which companies are listed alongside Misti?
32 profiles list Misti as a peer — 98th percentile in Biotechnology. It lists ten peers of its own. Tessara Therapeutics and Pacalis Therapeutics Pty Ltd list it back.